📑 Table of Contents (Quick Navigation)
- 1. Why Transperineal Biopsy Has Replaced Transrectal TRUS Biopsy as the EAU Gold Standard
- 2. 4-Column Comparison: Freehand Coaxial Transperineal MRI-Fusion vs. Grid Template TP vs. Transrectal TRUS Biopsy
- 3. Step-by-Step Freehand Coaxial Transperineal Biopsy Protocol in Da Nang
- 4. Frequently Asked Questions (FAQ) With Dr. Dang Phuoc Dat
- Medical References (Vancouver Style)
Author & Medical Reviewer: Dr. Dang Phuoc Dat, MD, Specialist Level I – Consultant Urologist, Prostate Specialist & Andrologist (Family Hospital Da Nang & 162 Te Hanh Private Clinic)
Clinical Executive Summary: For international patients and expats requiring histopathologic evaluation for suspected prostate cancer, the European Association of Urology (EAU 2026) Guidelines give a strong Level 1a recommendation to perform prostate biopsy via the Transperineal (TP) route rather than the conventional Transrectal (TR) route. By passing the biopsy needle through surgically sterilized perineal skin instead of the bacteria-laden rectal wall, Transperineal MRI-Ultrasound Fusion Prostate Biopsy reduces life-threatening urosepsis from 2%–5% down to near 0% (< 0.1%), completely eliminates rectal bleeding, and increases detection of clinically significant anterior and apical prostate cancers by 15%–20%.
1. Why Transperineal Biopsy Has Replaced Transrectal TRUS Biopsy as the EAU Gold Standard
Historically, standard Transrectal Ultrasound-Guided Biopsy (TRUS Biopsy) required puncturing the rectal mucosa 12 times with a core needle. Despite pre-procedural fluoroquinolone or cephalosporin antibiotics, each needle pass translocates fecal bacteria (such as multidrug-resistant ESBL-producing Escherichia coli) directly into the vascular prostatic parenchyma. As confirmed by the landmark multicenter randomized PREVENT Clinical Trial (JAMA Oncology / NCBI PMC), transperineal prostate biopsy achieved zero infectious hospitalizations (0%) even without prophylactic antibiotics, compared to significant infectious complications in the transrectal arm [1, 2].
Beyond infection control, Transperineal Prostate Biopsy: The Modern Gold Standard (NCBI PMC) highlights a crucial anatomical advantage: Because the transperineal needle enters longitudinally parallel to the prostatic urethra from the apex toward the base, it directly samples the anterior fibromuscular stroma and extreme prostatic apex—regions where 20% to 25% of clinically significant tumors hide and are routinely missed by angled transrectal needles [2, 3].
CLINICAL VISUAL DIAGRAM: THE MRI-FIRST DIAGNOSTIC PATHWAY (PI-RADS v2.1 TO TRANSPERINEAL BIOPSY)
| 3.0T Multiparametric MRI (PI-RADS v2.1 Score) | Risk of Clinically Significant Cancer (ISUP Grade ≥ 2) | Evidence-Based Biopsy Strategy With Dr. Dang Phuoc Dat |
|---|---|---|
| PI-RADS 1 – 2 (Negative / Benign BPH) | Very Low (< 5% – 8% probability of ISUP ≥ 2 cancer). | Safely Defer Biopsy if PSA Density (PSAD) < 0.15 ng/mL/cm³; continue longitudinal PSA monitoring. |
| PI-RADS 3 (Equivocal / Intermediate Zone) | Intermediate risk (15% – 25% probability of ISUP ≥ 2 cancer). | Risk-stratify with PSA Density (PSAD): Perform targeted + systematic Transperineal Biopsy if PSAD ≥ 0.15 ng/mL/cm³ or Free/Total PSA < 15%. |
| PI-RADS 4 – 5 (High / Very High Suspicion) | High probability (50% – 85%+ risk of clinically significant cancer on DWI/ADC & DCE). | Mandatory Transperineal MRI-Targeted Biopsy (3–4 targeted cores per lesion + 10–12 systematic Ginsburg sector cores). |
2. 4-Column Comparison: Freehand Coaxial Transperineal MRI-Fusion vs. Grid Template TP vs. Transrectal TRUS Biopsy
Comparing Diagnostic Yield, Infection Safety, and Patient Comfort
| Clinical Parameter | Freehand Coaxial Transperineal MRI-Fusion (Modern Standard) | Brachytherapy Grid Template Transperineal Biopsy | Conventional Transrectal TRUS Biopsy |
|---|---|---|---|
| Number of Skin / Mucosal Punctures | Only 2 skin punctures (1 coaxial access cannula on each side of the perineal raphe) | 12 to 24 separate perineal skin punctures through a stepper grid | 12 separate punctures through the unsterile rectal mucosa |
| Post-Biopsy Sepsis / Fever Risk | 0% – 0.1% (Sterile perineal skin route) | 0% – 0.1% | 1.5% – 5.0% hospitalization for febrile UTI / urosepsis |
| Rectal Hemorrhage Risk | 0% (Rectal wall and hemorrhoidal plexus untouched) | 0% | 15% – 30% rectal bleeding (1%–2% severe bleeding requiring tamponade) |
| Anesthesia & Urinary Retention Risk | Outpatient Periprostatic Local Block or Light Sedation; low retention rate (~1%) | Requires general/spinal anesthesia; higher urinary retention (5%–10%) | Local block; 1%–2% retention rate |
3. Step-by-Step Freehand Coaxial Transperineal Biopsy Protocol in Da Nang
Following the technical framework described in Journal of Endourology (NCBI PMC – Free-Hand Transperineal Prostate Biopsy Under Local Anesthesia) and the EAU Prostate Cancer Guidelines, Dr. Dang Phuoc Dat, MD, Specialist Level I performs the procedure in 15 to 20 minutes [3, 4]:
- Surgical Perineal Antisepsis & Two-Point Local Block: With the patient in a comfortable lithotomy position, the scrotum is gently elevated with tape and the perineal skin is prepped with Povidone-Iodine/Chlorhexidine. Two tiny intradermal wheals of 1% Lidocaine are placed 1.5 cm lateral to the midline, followed by ultrasound-guided infiltration of the pelvic floor (levator ani) and periprostatic neurovascular bundles (or optional short IV propofol sedation).
- Coaxial Introducer Cannula Placement: A single coaxial guide needle is inserted on the right and left perineum, allowing all 18-gauge spring-loaded biopsy cores to pass through the cannula without repeatedly piercing the skin.
- MRI-Ultrasound Target Sampling + Ginsburg Sector Mapping: Real-time biplane transrectal ultrasound is aligned with the patient's 3.0T multiparametric MRI lesion map to obtain 3–4 targeted cores from any PI-RADS 3–5 lesion, plus systematic cores from the anterior, apical, mid, and basal peripheral zones.
⚠️ PRE- AND POST-BIOPSY SAFETY INSTRUCTIONS FOR PATIENTS
Patients taking oral anticoagulants or antiplatelet agents (Warfarin, Rivaroxaban, Apixaban, Clopidogrel, or high-dose Aspirin) must coordinate with Dr. Dat 5 to 7 days prior to biopsy for safe bridging or temporary cessation. After biopsy, mild pink-tinged urine for 2–3 days and rust-colored semen (hematospermia) for 3–6 weeks are harmless expected findings; however, seek immediate care if you experience inability to pass urine (acute urinary retention from transient prostatic edema) or fever > 38.0°C.
4. Frequently Asked Questions (FAQ) With Dr. Dang Phuoc Dat
Question 1: If I had a negative transrectal biopsy in the past, why might a repeat transperineal biopsy find cancer?
Answer: Clinical studies published in Translational Andrology and Urology (NCBI PMC) demonstrate that in men with persistently rising PSA after a negative transrectal biopsy, repeat biopsy via the MRI-targeted transperineal route detects clinically significant prostate cancer in 35% to 45% of cases—predominantly in the anterior fibromuscular zone and extreme apex that the transrectal needle could not reach.
Question 2: Should a 3.0 Tesla multiparametric MRI always be performed BEFORE a prostate biopsy?
Answer: Yes! Performing a prostate biopsy first causes intraprostatic hemorrhage artifacts that take 6 to 8 weeks to resolve and obscure MRI interpretation. Therefore, the EAU 2026 Guidelines strongly mandate an “MRI-First” pathway: obtain a 3.0T multiparametric MRI prior to biopsy so any suspicious PI-RADS 3–5 focus can be precisely targeted on the first pass.
Question 3: How soon can I return to exercise and travel after a transperineal prostate biopsy in Da Nang?
Answer: Patients walk out of the clinic 1 to 2 hours after passing urine comfortably. Normal walking and desk work resume the next day; avoid heavy lifting, cycling, and vigorous gym workouts for 3 to 5 days. Full English histopathology reports (Gleason Score and ISUP Grade Group 1–5) are finalized within 3 to 5 business days.
Medical References (Vancouver Style)
- Hu JC, Assel M, Allaf ME, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–Targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. JAMA Oncol. 2024;10(11):1590-1593. (NCBI PMC)
- Ortner G, Tzanaki E, Rai BP, et al. Transperineal prostate biopsy: The modern gold standard to replace transrectal biopsy. Turk J Urol. 2021;47(Supp 1):S19-S26. (NCBI PMC)
- Szabo RJ. Free-Hand Transperineal Prostate Biopsy Under Local Anesthesia: Review of Technique, Pain Control, and Outcomes. J Endourol. 2021;35(4):525-543. (NCBI PMC)
- Cornford P, Tilki D, van den Bergh RCN, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer: MRI-Targeted Transperineal Biopsy. Arnhem: European Association of Urology; 2026. (EAU Guidelines)
Dr. Dang Phuoc Dat, MD, Specialist Level I – Consultant Urologist, Prostate Specialist & Andrologist (Over 10 years of clinical surgical experience in Da Nang).
📞 Direct English Hotline / Zalo / WhatsApp: 07777 43 777 | Zalo Chat: zalo.me/0777743777 | Websites: tuyentienliet.com & bacsidanang.com
Select any symptoms or concerns you are currently experiencing to see your recommended triage level before messaging Dr. Dang Phuoc Dat:
